Assessment of the clinical efficacy of surgical treatment for cervical lymph node tuberculosis
Objective To assess the effectiveness and practical value of surgery in clinical treatment of cervical lymph node tuberculosis.Methods 110 patients receiving surgical treatment for tuberculosis at Hunan Provincial Chest Hospital between January 2020 and December 2022 were selected,all of whom were diagnosed with cervical lymph node tuberculosis.According to patient preferences,they were divided into two groups,a drug treatment group consisted of 60 patients receiving conventional Western medicine treatment and a surgical treatment group of 50 patients receiving surgical treatment.Statistical analysis was made to compare the clinical efficacy,recurrence rate,complications,quality of life,and patient satisfaction between the two groups.Results The overall clinical effectiveness rate was higher in the surgical treatment group than in the drug treatment group(94.00％vs.70.00％,X2=10.170,P=0.001),with the rate higher in the surgical treatment group than in the drug treatment group for patients under 60 years of age(64.29％vs.40.00％,x2=-6.996,P=0.035),but there was no difference in therapeutic efficacy between the two groups for patients aged 60 and above(54.55％vs.40.00％,Z=3.842,P=0.146).Compared with the drug treatment group,the surgical treatment group had a lower recurrence rate(8.00％vs.46.67％,X2=19.767,P＜0.001)and a lower rate of complications(8.00％vs.21.67％,x2=3.899,P=0.048),but higher scores of quality of life in all four domains(physical function:64.02±4.49 vs.76.11±4.47,t=14.090,P＜0.001;material life:66.50±2.39 vs.81.03±2.28,t=32.417,P＜0.001;psychological function:62.98±2.51 vs.79.24±2.50,t=33.892,P＜0.001;social function:63.12±3.39 vs.76.08 ±3.51,t=19.645,P＜0.001)and a higher level overall patient satisfaction(90.00％vs.66.67％,X2=8.455,P=0.004).Conclusions Surgical treatment for cervical lymph node tuberculosis patients has better efficacy,fewer complications and better prognosis and is clinically practical and highly valuable.
万方数据
维普
